Reuters Health News Summary

Following is a summary of current health news briefs. Insomnia common among cancer patients

Roughly half of patients with cancer have symptoms of insomnia, and many may have sleep problems that linger for at least a year, a small study suggests. Up to 10 percent of adults in the developed world suffer from chronic insomnia, and cancer patients are particularly prone to it, researchers note in Sleep Medicine. Even though sleep disorders have been tied to worse outcomes for cancer patients, research to date on hasn't offered a clear picture of what circumstances might make sleep problems more likely in people being treated for tumors. Ebola spread concentrated in Congo, not a wider emergency: WHO

An outbreak of Ebola in the Democratic Republic of Congo (DRC) that has killed more than 700 people and is continuing to spread does not constitute an international emergency, the World Health Organization said on Friday. Declaring the epidemic a "public health emergency of international concern" would have signaled that greater resources and international coordination are needed. Johnson & Johnson wins U.S. FDA approval for bladder cancer drug

Johnson & Johnson's drug Balversa won U.S. approval as the first targeted therapy for advanced bladder cancer, the Food and Drug Administration announced on Friday. The list price of the drug, known chemically as erdafitinib, will range between $10,080 to $22,680 for a 28-day supply, depending of the dose, J&J said. Female firefighters' health needs often unaddressed

Women firefighters, particularly in North America, are less likely to have access to female-specific personal protective equipment and appropriate strength training and conditioning support, according to a new study. In addition, women reported numerous counts of sexism on the job, and others talked about logistical issues such as sanitary conditions and toilet facilities, especially when tackling fires for several hours, researchers wrote in Women's Health Issues. U.S. CDC says ground beef possible source of E.coli outbreak

The U.S. Centers for Disease Control and Prevention said on Friday preliminary information suggested ground beef could be responsible for a recent E.coli outbreak that has spread across six states. No common supplier, distributor, or brand of ground beef has been identified yet and the CDC said the investigation was ongoing. (http://bit.ly/2KwyHhl) French court finds Bayer's Monsanto liable for farmer's sickness

A French court has ruled that Monsanto was liable for the sickness of a farmer who inhaled one of its weedkillers, in another legal setback for the Bayer-owned business over health claims. In the latest stage of a decade-long legal tussle, the appeals court in Lyon on Thursday found in favor of farmer Paul Francois' claim that Monsanto's Lasso weedkiller had made him sick and that the product's labeling had been inadequate. Caito Foods recalls fresh cut melon over Salmonella outbreak

An Indianapolis food company has voluntarily recalled fresh cut melon produced at its facility after reports of nearly 100 illnesses tied to Salmonella contamination. Caito Foods LLC, a unit of SpartanNash Co., suspended production and distribution of pre-cut watermelon, honeydew melon, cantaloupe and mixed fruit containing one of those melons, the U.S. Food and Drug Administration said in a statement issued on Friday. Bayer says to comply with court mediation order in glyphosate case

Bayer said on Friday it would comply with a U.S. federal judge's order to enter mediation with a plaintiff who claims the company failed to warn against an alleged cancer risk from its Roundup weedkiller. Bayer has seen billions wiped off its market value since August, when a first U.S. jury found Bayer liable because Monsanto, acquired by Bayer for $63 billion last year, had not warned of the alleged risk from Roundup, which is based on active ingredient glyphosate. Clovis Oncology halts mid-stage bladder cancer trial, shares drop

Clovis Oncology Inc said on Friday it was halting a mid-stage trial testing its lead drug in bladder cancer patients, sending shares down 12 percent. The company said its decision to discontinue the trial was based on recommendations of an independent committee, which suggested that the treatment may not provide a meaningful benefit to patients. FDA pulls up Walmart, Kroger, others for selling tobacco to minors

The U.S. Food and Drug Administration (FDA) said on Friday it has sent letters to Walmart Inc, Kroger Co and 10 other convenience store chains for selling tobacco products to minors. In the letters, dated April 5, the FDA asked the companies to submit a plan of action within 30 days, describing how they will address and mitigate illegal sales to minors.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)